Synthetic lipopeptide that suppresses interleukin-6 (IL-6), a pro-inflammatory cytokine. Part of the Matrixyl 3000 complex alongside palmitoyl tripeptide-1.
Topical application
CWeak evidence. In vitro data, open-label studies, or expert consensus.
In vitro IL-6 suppression and glycation reduction confirmed. Clinical data limited to small industry studies within the Matrixyl 3000 combination. The isolated contribution of tetrapeptide-7 is hard to separate from the combination.
Palmitoyl Tetrapeptide-7 (Rigin) is a synthetic lipopeptide: the tetrapeptide Gly-Gln-Pro-Arg with palmitic acid. An anti-aging peptide with claimed anti-inflammatory action. Mechanism. Claimed suppression of IL-6 production in keratinocytes under UV-stress induction (Sederma). By reducing chronic inflammation (inflammaging) protects collagen and elastin from degradation. Where applied. Anti-aging serums and creams. Often combined in formulas with matrixyl (Palmitoyl Pentapeptide-4) – the commercial complex Matrixyl 3000. Formula concentration 2–5 ppm. Evidence base. Few independent RCTs. Manufacturer's evidence shows reduction in signs of photoaging. No systematic review. Safety. CIR confirmed safety. Hypoallergenic, non-comedogenic. Pregnancy and lactation – manufacturers advise caution. No direct pregnancy data.
Irritation potential
LowAllergen risk
LowPregnancy
UnknownSuitable for
The Evigrade extension adds an evidence panel to Wildberries, Goldapple, Letu, iHerb, Sephora and 12 more stores. This ingredient and every other one in the product show evidence-tier, allergen risk and pregnancy/lactation flags at a glance.
Safety data for Palmitoyl Tetrapeptide-7 during pregnancy is insufficient. Best avoided when in doubt.
Palmitoyl Tetrapeptide-7 suits: normal, dry, sensitive, combination.
Synthetic lipopeptide that suppresses interleukin-6 (IL-6), a pro-inflammatory cytokine.
The INCI name is Palmitoyl Tetrapeptide-7. It may also appear as: Matrixyl 3000 (part).
Published: · updated: